Yokneam, Israel and Plymouth Meeting, PA, March 25, 2008 – Galil Medical, a global cryotherapy company, today announced that Martin J. Emerson has been appointed President and Chief Executive Officer. Galil Medical is a market leader in cryotherapy technology for the minimally invasive treatment of cancerous and non-cancerous tumors.

 

Mr. Emerson is an experienced and successful medical device industry executive, and was most recently President and CEO of American Medical Systems (AMS). He will be replacing Chen Barir, who will continue to serve on the Galil Medical Board of Directors.

 

Chen Barir commented, “Galil Medical is very pleased to have been able to attract an executive with the leadership experience and stature of Marty Emerson. We are confident that Marty will be able to help Galil Medical sustain the growth that has been recorded since our December 2006 reorganization and recapitalization financing.”

 

"I am very excited to be joining Galil Medical," said Mr. Emerson. "The company has developed innovative cryotherapy solutions to treat prostate cancer and renal tumors and has a promising product pipeline for the Women’s Health and Interventional Radiology markets. I look forward to working with the talented team to expand the opportunities for Galil Medical’s industry leading technology around the globe.”

 

Mr. Emerson has a strong track record of over 20 years of accomplishments in the medical device industry, most recently as President and Chief Executive Officer of AMS. During his tenure at AMS, he held executive roles including Vice President and General Manager of International, Executive Vice President of Global Sales and Marketing and Chief Operating Officer. Prior to joining AMS, he held senior roles in the overseas operations for several American-based companies including Baxter International and Boston Scientific.